Purification and properties of the catalytic domain of human 3-hydroxy-3-methylglutaryl-CoA reductase expressed in Escherichia coli
- 2 November 1988
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 267 (1) , 110-118
- https://doi.org/10.1016/0003-9861(88)90014-8
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Lipid-Lowering DrugsDrugs, 1987
- Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzymeCell, 1985
- Expression and characterization of the human c-myc DNA-binding protein.Molecular and Cellular Biology, 1985
- The LDL Receptor and HMG-CoA Reductase — Two Membrane Molecules That Regulate Cholesterol HomeostasisPublished by Elsevier ,1985
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- Purification of β-hydroxy-β-methylglutaryl-coenzyme A reductase from yeastBiochemistry, 1976
- Tight-binding inhibitors—IBiochemical Pharmacology, 1975
- 3-Hydroxy-3-methylglutaryl Coenzyme A ReductasePublished by Elsevier ,1973
- The determination of enzyme inhibitor constantsBiochemical Journal, 1953